Winnipeg firm Regenetek issues statement explaining role in MS study
Friday, January 16, 2015 - 19:00
in Health & Medicine
A Winnipeg-based company says it stands behind its role in a study involving an experimental treatment for multiple sclerosis, while at least three patients in Canada have brought concerns about the company's CEO to the RCMP.